Clinical trials
Completed Metabolic Diseases trials in India
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2009 | 5 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2017 | 1 |
| 2020 | 1 |
| 2022 | 3 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Eli Lilly and Company | 4 |
| Regeneron Pharmaceuticals | 2 |
| 89bio, Inc. | 1 |
| Bayer | 1 |
| Ionis Pharmaceuticals, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Respyr | 1 |
| Sumitomo Pharma Switzerland GmbH | 1 |
| Takeda | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 18 |
| Diabetes Mellitus, Type 2 | 11 |
| Diabetes Mellitus | 9 |
| Glucose Metabolism Disorders | 8 |
| Endocrine System Diseases | 7 |
| Genetic Diseases, Inborn | 3 |
| Metabolism, Inborn Errors | 3 |
| Musculoskeletal Diseases | 3 |
| Arthritis | 2 |
| Gout | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.